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Abstract
Background: Nucleic acid amplification tests (NAATs) have proven to be advantageous in the diagnosis of
leishmaniases, allowing sensitive diagnosis of: (i) cutaneous leishmaniasis in long duration lesions and (ii) visceral
leishmaniasis using a less-invasive sample like peripheral blood, in opposition to tissue aspiration required for
parasite demonstration by microscopy. Despite their benefits, the implementation of NAATs for leishmaniasis
diagnosis at the point-of-care has not been achieved yet, mostly due to the complexity and logistical issues
associated with PCR-based methods.
Methods: In this work, we have evaluated the performance of a ready-to-use loop-mediated isothermal
amplification (LAMP) kit using two real time fluorimeters to amplify leishmanial DNA obtained by silica column-
based and Boil & Spin protocols.
Results: The different approaches used to run and interpret the LAMP reactions showed a performance equivalent
to PCR and real-time PCR, using spiked and clinical samples. The time to positivity obtained with real-time
fluorimetry showed an excellent correlation with both Ct values and parasite load from real-time quantitative PCR.
Conclusions: The results obtained open the possibility of using a highly stable, ready-to-use LAMP kit for the accurate
diagnosis of leishmaniasis at the point-of-care. Furthermore, the feasibility of relating time to positivity, determined
with a portable real-time fluorimeter, with the parasite burden could have a wider application in the management of
leishmaniasis, such as in treatment efficacy monitoring or as a pharmacodynamics tool in clinical trials.
Keywords: Leishmaniasis, Visceral leishmaniasis, Diagnostics, Loop-mediated isothermal amplification, LAMP, Less-
invasive diagnosis, Non-invasive diagnosis, Loopamp™ Leishmania detection kit, Real-time fluorimeters, Boil & Spin
Background
The loop-mediated isothermal amplification (LAMP)
method enables the robust, fast, simple and highly specific
amplification of nucleic acids. Since it was developed,
LAMP has been used in several molecular diagnostic ap-
plications [1, 2]. In the field of infectious diseases it has
made possible the diagnosis at the point-of-care (POC)
level. For example, LAMP kits have been successfully
developed for malaria and tuberculosis by the Eiken
Chemical Co. (Japan), and the latter was recently endorsed
by the World Health Organization [3–5]. The develop-
ment of simple and easy-to-implement nucleic acid ampli-
fication tests (NAATs) such as LAMP has gained
attention as these methods could enable accurate diagno-
sis at the POC in developing countries where access to
laboratories is limited [6].
A LAMP kit for the diagnosis of leishmaniasis at the
POC, the Loopamp™ Leishmania Detection Kit, has been
recently developed by the Eiken Chemical Co., FIND
and partners. This LAMP test uses primers targeting the
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18S rRNA gene and the kDNA minicircles, and is
specific for the genus Leishmania. The kit is in a ready-
to-use format and is composed of dried-down reagents,
including primers, Bacillus stearothermophilus (Bst)
DNA polymerase and calcein, so that no cold chain for
transport and storage is required, and reactions can be
set up at ambient temperature. The kit allows for differ-
ent approaches to detect the amplified products. Before
amplification, calcein contained in the dried reagents in
each of the reaction tubes is in a quenched state, bound
to manganese ions. Once the LAMP reaction starts, the
pyrophosphate ions that are generated bind to the man-
ganese ions, releasing calcein, thus generating fluores-
cent light that is detectable by the naked eye. This signal
can be enhanced by illumination with UV or blue light.
Real-time monitoring of the fluorescence associated to
the amplification is possible using a fluorimeter, and it is
also possible to assess the amplification using a real-time
turbidimeter to measure the turbidity caused by the pre-
cipitation of magnesium pyrophosphate, a by-product of
the reaction.
LAMP can amplify target DNA in different biological
matrices and even in the presence of fresh blood compo-
nents that usually inhibit PCR reactions, such as haemo-
globin, IgG or IgM [7, 8]. However, there can be
situations where the visual assessment of the amplified
products can be challenging, like in crude DNA lysate
preparations from blood [9, 10]. In addition, direct
examination of changes in fluorescence intensity with
the naked eye, even under UV or blue light, is dependent
on, often subjective, human interpretation. To overcome
these problems a number of approaches have been de-
veloped during the last decade to improve the detection
of the amplified products either by end-point or real-
time assessment, including electrochemical, optical and
pH-sensing-based detection systems [8, 11]. Various in-
cubators that can be used to run LAMP reactions are
commercially available. Some of them, such as the LF-
160 (Eiken Chemical Co., Japan), are designed for visual
assessment of test results by naked eye using a blue
light. Others, such as the LA-320C (Eiken Chemical Co.)
can perform real-time turbidity measures. Both the LF-
160 and the LA-320C are designed to accommodate
LAMP reaction tubes made by Eiken Chemical, whose
shape is slightly different from standard PCR tubes. By
contrast, incubators made by other manufacturers are
usually not designed for Eiken Chemical tubes. For ex-
ample, the Genie III® (OptiGene Limited, Horsham, UK)
is a compact, portable, battery-operated incubator in-
cluding real-time fluorimetry, which is designed to ac-
commodate standard PCR tubes. In 2014, FIND
facilitated a modification of the design of the Genie III®
by OptiGene so that it could be used with LAMP tubes
made by Eiken Chemical. FIND also supported a study
at the Institute of Primate Research (Kenya) to compare
the LF-160, the LA-320C and the Genie III® using the
Loopamp™ Trypanosoma brucei Detection Kit produced
by Eiken Chemical (manuscript in preparation). To con-
tribute to this subject we evaluated the performance of
the Loopamp™ Leishmania Detection Kit using two dif-
ferent real-time fluorimeters and an incubator with
coupled blue LED light illumination.
Methods
Study site
The study was conducted at the WHO Collaborating
Centre for Leishmaniasis, National Centre for Microbiol-
ogy, Instituto de Salud Carlos III, Madrid, Spain
(WHOCCL-ISCIII), which is also the national reference
laboratory for leishmaniasis.
Biological materials
The following biological materials were used to create the
panels tested in the three experiments described below: (i)
Leishmania infantum promastigotes (strain MHOM/ES/
2014/LLM-2240) cultured in Novy-MacNeal-Nicolle
medium medium; (ii) heparin-treated peripheral blood
and bone marrow samples from confirmed and non-
confirmed visceral leishmaniasis (VL) suspects stored at
-20 °C at the WHOCCL-ISCIII collection on leishmania-
sis, registered at the National Biobank Register, Section
Collections, Spain with the collection Reference ID: C.
0000898; and (iii) freshly collected heparin-treated periph-
eral blood from a healthy volunteer.
DNA extraction procedures
DNA was purified from pellets of cultured L. infantum
promatigotes and from 95 μl of heparin-treated periph-
eral blood and bone marrow aspirates using the QIAamp
DNA Mini Kit (Qiagen, Hilden, Germany). The DNA
was eluted in 100 μl PCR grade water and processed im-
mediately or stored at -20 °C until analysis. When DNA
was extracted from L. infantum promastigotes its con-
centration was estimated using a NanoDrop™ spectro-
photometer (Thermo Scientific, Wilmington, USA) and
adjusted according to the experiments described below.
Measures were taken in duplicates. Additionally, DNA
was also purified from biological samples using a “Boil &
Spin” protocol, as follows: 95 μl heparin-treated whole
blood or bone marrow aspirate was mixed with 5 μl 10%
SDS by inversion 10 times in a 1.5 ml microcentrifuge
tube with screw cap, allowed to stand for 10 min at
room temperature and mixed again. After adding 400 μl
PCR grade water the mix was incubated in a heating
block at 90 °C for 10 min. The mix was then spun for 3
min at maximum speed in a bench top microcentrifuge
(13,000× rpm) and the supernatant containing the DNA
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was recovered and processed immediately or stored at
-20 °C until analysis.
Nucleic acid amplification tests
LAMP
LAMP reactions using the Loopamp™ Leishmania De-
tection Kit (Eiken Chemical Co.) were performed using
3 μl purified DNA and run in two different fluorimeters
and one incubator, as described below.
Nested PCR and real-time quantitative PCR
DNA samples were also tested by Leishmania nested-
PCR (LnPCR) and real-time quantitative PCR (qPCR),
both targeting the 18S rRNA (SSU rRNA) gene. Bio-
logical samples from the WHOCCL-ISCIII collection
had been previously tested by LnPCR, with VL con-
firmed cases being positive, and non-confirmed VL sus-
pects and healthy controls being negative. This test was
repeated in this study to confirm sample integrity.
LnPCR was performed with 3 μl DNA following the
procedure described elsewhere [12]. qPCR was also per-
formed with 3 μl DNA using a LightCycler 2.0 high
speed thermal cycler and the LightCycler FastStart DNA
Master SYBR Green I kit (Roche Diagnostics, Mannhein,
Germany) following the protocol described elsewhere.
Quantification was accomplished by means of a standard
curve which consisted of serial dilutions of L. infantum
DNA (strain JPC, MCAN/ES/98/LLM-722) ranging from
the equivalent of 104 to 10-7 parasites/μl [13, 14].
All LAMP, LnPCR and qPCR runs included positive
(DNA equivalent to 104 parasites/μl) and negative
controls (DNA from peripheral blood from a healthy
volunteer). LAMP, LnPCR and qPCR reactions were run
in duplicate.
Incubators/fluorimeters and interpretation of LAMP
results
Loopamp™ Leishmania Detection Kit reactions were car-
ried out in three different devices that allowed for the
isothermal incubation required for the LAMP reaction.
LAMP reactions were set up in all devices to run for 40
min at 65 °C. A final step of 80 °C for 5 min was applied
to inactivate the Bst DNA polymerase.
LF-160 incubator
LF-160 incubator (Eiken Chemical Co.), now commer-
cialized as HumaLoop M incubator (HUMAN, Wies-
baden, Germany), is a benchtop device for isothermal
amplification. Results were visualized under blue LED
light illumination, using the Fluorescence Visual
Check Unit integral to the incubator [15]. Positive
samples emit a green fluorescent light. Negative sam-
ples do not emit any light.
Genie III® real-time fluorimeter
The Genie III® (OptiGene Ltd.) is a hand-held, battery
operated, device for isothermal amplification and real-
time fluorescence detection at the point-of-care. Further
information can be found elsewhere [16]. The Genie III®
heat block was customized to match the dimension of
the Loopamp™ Leishmania detection tubes and prevent
tubes from opening during incubation. To allow for the
measurement of the LAMP fluorescence, the Genie III®
was set up for 470 nm excitation and 510–560 nm on
the detector side. Prior to using the device for sample
measurements, the gain of the detector was adjusted
using positive and negative control wells from the Loop-
amp™ kit.
ESEQuant TS2.2 real-time fluorimeter
The ESEQuant TS2.2 (Qiagen Lake Constance GmbH)
is a benchtop device for isothermal amplification and
real-time fluorescence detection. Further information
can be found elsewhere [17]. Fluorescence was moni-
tored setting the dual fluorescence channel to 470 nm
and 520 nm for excitation and emission, respectively.
Prior to using the device for sample measurements, the
gain of the detector was adjusted using positive and
negative control wells from the Loopamp™ kit.
When using the fluorimeters, positive or negative re-
sults, as well as amplification time to positivity (Tp) in
the Genie III®, were recorded upon examination of the
amplification curves.
Serological and parasitological tests in samples from VL
suspects and healthy controls
Before their inclusion in the WHOCCL-ISCIII collec-
tion, samples were characterized, when applicable, by
serological and parasitological methods as follows. All
the samples from non-confirmed VL suspects and
healthy negative controls had a negative result by both
the serological and parasitological methods described
below.
Immunofluorescent antibody test (IFAT)
Plasma samples (1 μl) from VL suspects and healthy
controls were tested by an in-house IFAT following a
standard method [18]. In this method the antigen is pre-
pared from L. infantum promastigotes (strain MHOM/
FR/78/LEM-75) and antibody binding is detected using
fluorescein isothiocyanate-conjugated sheep anti-human
immunoglobulin G (heavy and light chains). The thresh-
old titre for positivity is ≥ 1/80.
Parasitology in bone marrow aspirates from VL suspects
Bone marrow aspirates were also used to prepare
Giemsa smears and/or inoculate NNN cultures. Slides
were examined at 1000× magnification for at least 1 h.
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NNN cultures were maintained at 27 °C, sub-cultured
and examined by light microscopy on a weekly basis for
at least 4 weeks before a negative result was returned.
Panel of experiments
The following experiments were conducted to evaluate
the performance of LoopampTM Leishmania Detection
Kit using different methods to run the LAMP reaction
and read the results.
Experiment 1
Ten-fold serial dilutions ranging from 103 to 10-7
parasite equivalents/μl were prepared with DNA
obtained from L. infantum promastigotes with the
QIAamp DNA Mini Kit. We assumed 200 fg DNA as
the equivalent to one parasite [13]. Three μl of each
dilution were used in the LAMP, LnPCR and qPCR
reactions in this and the other two experiments
described below.
Experiment 2
Leishmania infantum promastigotes from stationary
phase culture were counted in a Neubauer chamber,
their number adjusted and mixed with heparin-treated
peripheral blood from healthy negative control to pre-
pare serial 10-fold dilutions of 200 μl each, ranging from
103 to 10-2 parasites/μl. Ninety-five microliters was used
in each DNA extraction method described above
(QIAamp DNA Mini Kit and Boil & Spin).
Experiment 3
DNA was obtained by Boil & Spin and the QIAamp
DNA Mini Kit from 95 μl aliquots of five heparin-
treated human peripheral blood samples and five bone
marrow aspirate samples from patients with suspected
VL, which had been received at the WHOCCL-ISCIII
between September and October 2015 and stored in
their collection at -20 °C. These VL suspects were classi-
fied as confirmed or non-confirmed cases based on pre-
vious LnPCR, IFAT and parasitology results.
Correlation analysis
In Experiment 1 we recorded data on time to positivity
(Tp) for LAMP, obtained with the Genie III® fluorimeter,
and qPCR cycle threshold (Ct) and parasite load. We es-
timated the Spearman’s correlation coefficient between
Tp and both Ct and parasite load. These analyses were
performed with SPSS software (IBM SPSS Statistic 22)
and GraphPad Prism v.7.0 (GraphPad Software, San
Diego, USA).
Results
The identification of positive results by examination of
the amplification curves obtained with the Genie III®
and ESEQuant TS2.2 fluorimeters was quite straightfor-
ward. Likewise, visualization under blue LED light illu-
mination with the LF-160 incubator allowed easy
detection of positive (green) and negative (colourless)
samples (Fig. 1).
Fig. 1 LAMP reaction results in Experiment 2 with the three different approaches proposed in this study. a Visual inspection under blue LED light
illumination (Incubator LF-160) (POS, positive control; NEG, negative control; 103 to 10-2 parasites/μl equivalents). b Amplification curves obtained
using the real-time fluorimeter Genie III. Fluorescence in millivolts (mV) on the y-axis vs time (min) on the x-axis. c Amplification curves obtained
using the real-time fluorimeter ESE-Quant TS2.2. Fluorescence in millivolts (mV) on the y-axis (×100) vs time (min) on the x-axis
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Independently of the device used for isothermal ampli-
fication and detection, LAMP detected all L. infantum
DNA samples in the range prepared (103–10-3 parasite
equivalents/μl) in Experiment 1, while the limit of
detection for LnPCR and qPCR was 10-2 parasite
equivalents/μl (Table 1). We also observed a very strong
correlation between the Tp obtained with the Genie III®
fluorimeter and the Ct values from qPCR in the same
set of samples (Spearman’s r = 0.9895, P < 0.0001, 95%
CI: 0.9601–0.9972). Indeed, we also found a very strong
correlation between the Tp obtained with the Genie III®
fluorimeter and the parasite load determined by qPCR
(Spearman’s r = -0.9912, P < 0.0001, 95% CI: -0.9977–
-0.9666) (Fig. 2).
In Experiment 2 (serial 10-fold dilutions of L. infan-
tum promastigotes in heparin-treated peripheral blood),
all molecular tests and approaches used detected L.
infantum spiked samples in the range of 103 to 10-2
parasites/μl, independently of the method used for DNA
extraction (QIAamp DNA Mini Kit or Boil & Spin).
Experiment 3 showed a complete agreement between
LnPCR, qPCR and LAMP when it was run in the real-
time fluorimeters, independently of the DNA extraction
procedure used, as well as in the LF-160 incubator when
DNA samples were prepared with the QIAamp DNA
Mini Kit. However, when samples prepared with the Boil
& Spin method were run in the LF-160 incubator, the
examination under blue LED light returned three dis-
cordant results even after repeated testing (Table 2). It
was not possible to get a clear result for a bone marrow
aspirate from a VL confirmed patient (VL6), and two
samples from non-confirmed VL suspects (VL7-periph-
eral blood and VL8-bone marrow) returned a signal that
was judged as positive when all other tests were negative
(LnPCR, qPCR and LAMP as well as serology and
parasitology).
Discussion
Leishmaniasis is a neglected tropical disease that has its
largest impact on the poorest of the poor in endemic re-
gions, which quite often do not have access to an
accurate diagnosis due to a limited health service infra-
structure. Prompt diagnosis and treatment is key to re-
duce the morbidity and stigma associated with
cutaneous leishmaniasis (CL) and to avoid the chronic
wasting and death of those affected by visceral leishman-
iasis (VL) [19]. NAATs (principally PCR-based methods)
have proven to be advantageous in the diagnosis of
leishmaniasis, allowing the accurate diagnosis of CL
even in lesions of long duration. The latter has enabled
confirmatory diagnosis of VL using peripheral blood, in
opposition to more invasive procedures such as bone
marrow or splenic aspiration required for microscopy
[20–23]. The diagnosis and management of leishmaniasis
would benefit from the implementation of accurate
NAATs at the POC.
LAMP is a simple and robust NAAT, and different
studies have shown a number of applications of proto-
type LAMP tests in the field of leishmaniasis. Several
prototypes have shown to be useful in detecting Leish-
mania infection in sand flies, diagnosis of canine leish-
maniasis, human VL, CL and post-kala-azar dermal
leishmaniasis. In general, these studies have reported
high sensitivity and specificity assessing LAMP results
either using direct examination with the naked eye [24–
32], or fluorimetry or turbidimetry [33–35]. Regarding
fluorimetry, both Genie III® and ESEQuant TS2.2 devices
have been used in the diagnosis of different pathogens
using LAMP [36–41], to the best of our knowledge this
is the first time these approaches are used to detect
Leishmania DNA using the Loopamp™ Leishmania De-
tection Kit.
Our results with the Loopamp™ Leishmania Detec-
tion Kit and different detection systems show a strong
correlation with LnPCR and qPCR methods normally
employed by the WHOCCL-ISCIII for the diagnosis
of different forms of leishmaniasis as well as in epi-
demiological investigations [12–14, 42–49]. When
using DNA purified with the QIAamp DNA Mini Kit
LAMP returned a one-log higher analytical sensitivity
(equivalent to 10-3 parasites/μl) than LnPCR or qPCR
(10-2 parasites/μl), which might well be a reflection of
Table 1 Results obtained by using DNA isolated with QIAgen columns with the different instruments in Experiment 1
Instrument L. infantum 10-fold DNA dilutions of parasite equivalents/μl
103 102 10 1 10-1 10-2 10-3 10-4 10-5 10-6 10-7
LF-160 Pos Pos Pos Pos Pos Pos Pos Neg Neg Neg Neg
Genie III® Pos Pos Pos Pos Pos Pos Pos Neg Neg Neg Neg
Tp (min:sec) 13:30 14:30 16:15 17:45 21:45 24:00 34:15 0 0 0 0
ESEQuant TS2.2 Pos Pos Pos Pos Pos Pos Pos Neg Neg Neg Neg
LnPCR Pos Pos Pos Pos Pos Pos Neg Neg Neg Neg Neg
qPCR Pos Pos Pos Pos Pos Pos Neg Neg Neg Neg Neg
Ct 19.1 22.5 25.6 28.4 30.7 32.1 Neg Neg Neg Neg Neg
Abbreviations: Pos positive, Neg negative
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the number of copies per Leishmania genome of the
DNA targets in these NAATs (Experiment 1). It is worth
noting that while LnPCR and qPCR target the 18S rRNA
gene (> 100 copies/genome), the Loopamp™ Leishmania
Detection Kit targets both 18S rRNA and kDNA minicirles
(the later with > 1000 copies/genome) [50]. This high
sensitivity has been demonstrated in the set of clinical
samples from suspected VL cases included in this study.
When we used fresh blood spiked with L. infantum
promastigotes (Experiment 2), the LAMP test showed a
strong correlation with LnPCR and qPCR, independently
of the method used for DNA preparation. It was only in
clinical samples prepared with the Boil & Spin method
(Experiment 3) that we found three discrepancies when
the reactions were run in the LF-160 incubator and the
results examined by the naked eye under blue LED light.
This problem with naked eye examination of LAMP
results from crude DNA lysates from blood has been re-
ported elsewhere [9, 10]. As we did not see this problem
in Experiment 2, we suggest this might be related to the
use of fresh versus frozen stored samples, as the clin-
ical samples used in Experiment 3 were collected in
2015 and kept at -20 °C since then. We can speculate
that excess hemolysis in frozen samples affected the
interpretation of LAMP results by the naked eye when
DNA is prepared with the Boil & Spin method [51, 52].
The possibility of using a ready-to-use amplification kit
with a simple sample preparation method (Boil & Spin) and
a fluorimeter could be attractive for the diagnosis of visceral
leishmaniasis in resource-limited health infrastructures. The
accuracy of this approach for other clinical manifestations of
leishmaniasis such as cutaneous leishmaniasis or post-kala-
azar leishmaniasis should also be tested. In addition, the ac-
curate detection of asymptomatic dogs acting as reservoir
Fig. 2 Correlation between LAMP and qPCR in the same set of samples (103 to 10-2 parasites/μl), from Experiment 1. a Correlation between the
Tp obtained with the Genie III® fluorimeter and the Ct values from qPCR (Spearman’s r = 0.9895, P = 0.0001). b Correlation between the Tp
obtained with the Genie III® fluorimeter and parasite load from qPCR (Spearman’s r = -0.9912, P = 0.0001)
Table 2 Results obtained with the different instruments in each of the different experiments proposed. Discordant results are
shown in bold letters. Sample order in the table is the same as in LAMP analyses













VL1/C Peripheral blood Pos Pos Pos Pos Pos Pos Pos Pos
VL2/C Bone marrow aspirate Pos Pos Pos Pos Pos Pos Pos Pos
VL3/C Peripheral blood Pos Pos Pos Pos Pos Pos Pos Pos
VL4/C Peripheral blood Pos Pos Pos Pos Pos Pos Pos Pos
VL5/NC Bone marrow aspirate Neg Neg Neg Neg Neg Neg Neg Neg
VL6/C Bone marrow aspirate Pos Pos Unc Pos Pos Pos Pos Pos
VL7/NC Peripheral blood Neg Neg Pos Neg Neg Neg Neg Neg
VL8/NC Bone marrow aspirate Neg Neg Pos Neg Neg Neg Neg Neg
VL9/C Bone marrow aspirate Pos Pos Pos Pos Pos Pos Pos Pos
VL10/NC Peripheral blood Neg Neg Neg Neg Neg Neg Neg Neg
Abbreviations: ID Identification number in this study, Pos Positive result, Neg negative result, C confirmed VL case, NC non-confirmed VL case, Unc uncertain result
Ibarra-Meneses et al. Parasites & Vectors  (2018) 11:250 Page 6 of 9
for zoonotic visceral leishmaniasis and the confirmation of
canine visceral leishmaniasis cases in the field would be
valuable for the control of leishmaniasis.
In summary, our study shows a good performance of
the Loopamp™ Leishmania Detection Kit using different
devices for amplification and interpretation of results, as
well as different approaches for DNA preparation. The
use of real-time fluorimeters presents the additional ad-
vantage of an objective assessment of the amplification,
which is less affected by the background components
present in crude DNA lysates obtained with the Boil &
Spin method. Additional advantages of these fluorime-
ters is their portability and that they offer opportunities
for diagnostic connectivity using Wi-Fi or Bluetooth®
[16, 17]. The high correlation between LAMP Tp and
both qPCR Ct values and parasite load also opens the
possibility of exploring the use of real-time LAMP as a
semi-quantitative test, as proposed by other authors
[53–59]. Similarly, though not validated in this study,
the use of real-time turbidimeters would also provide
significant advantages in the interpretation of LAMP re-
sults [58, 59].
Conclusions
The Loopamp™ Leishmania Detection Kit has shown a
very good diagnostic performance in this small-scale
study, and the possibility of using a simple sample
preparation method (Boil & Spin) and a portable and
robust real-time fluorimeter opens an avenue for the
diagnosis of leishmaniasis at the POC, enabling treat-
ment when confirmatory diagnosis is required. This
test can support the diagnosis of VL in situations in
which serological diagnosis is useless such as in VL
relapses and test-of-cure, VL/HIV co-infection, and
the diagnosis of CL cases that require confirmatory
diagnosis to initiate systemic treatment, which often
presents high toxicity. This promising approach could
also be explored in veterinary public health for the
diagnosis of canine leishmaniasis.
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